Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
352.84
295.73
242.95
293.59
212.06
124.97
58.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
352.84
295.73
242.95
293.59
212.06
124.97
58.52
Raw Material Cost
193.41
157.27
116.53
120.54
96.40
73.41
34.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
62.33
42.26
25.12
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.75
3.17
3.31
5.13
4.86
2.60
2.77
Selling and Distribution Expenses
87.70
94.18
70.64
57.69
45.58
26.99
15.02
Other Expenses
3.76
2.44
3.08
2.06
-5.33
-2.74
-0.87
Total Expenditure (Excl Depreciation)
321.46
278.97
221.27
203.93
155.86
117.81
68.44
Operating Profit (PBDIT) excl Other Income
31.400000000000002
16.8
21.7
89.7
56.2
7.199999999999999
-9.9
Other Income
41.17
35.92
44.49
33.89
17.43
7.80
0.86
Operating Profit (PBDIT)
128.39
90.53
106.16
161.91
105.30
32.58
4.34
Interest
2.75
3.17
3.31
5.13
4.86
2.60
2.77
Exceptional Items
-17.79
4.63
1.53
1.67
-0.02
-0.00
0.00
Gross Profit (PBDT)
159.42
138.46
126.42
173.05
115.67
51.56
24.30
Depreciation
61.42
55.56
42.72
39.02
32.26
18.29
13.84
Profit Before Tax
46.43
36.43
61.67
119.43
68.15
11.68
-12.27
Tax
8.36
16.19
8.41
14.06
7.76
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.70
21.05
54.04
105.37
60.39
11.68
-12.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
41.70
21.05
54.04
105.37
60.39
11.68
-12.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.68
-0.82
-0.78
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.02
20.24
53.26
105.37
60.39
11.68
-12.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,100.47
2,096.75
2,158.62
2,184.68
562.45
493.99
78.44
Earnings per share (EPS)
0.37
0.18
0.47
0.92
0.53
0.1
-0.11
Diluted Earnings per share
0.37
0.18
0.47
0.92
0.53
0.1
-0.11
Operating Profit Margin (Excl OI)
7.31%
-0.32%
7.8%
30.32%
26.22%
5.19%
-17.7%
Gross Profit Margin
30.57%
31.1%
42.97%
53.97%
47.35%
23.99%
2.69%
PAT Margin
11.82%
7.12%
22.24%
35.89%
28.48%
9.35%
-20.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 19.31% vs 21.69% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 102.97% vs -62.10% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 59.71% vs -11.51% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -12.50% vs -3.03% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Shanghai OPM Biosciences Co. Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
352.84
0
352.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
352.84
0
352.84
Raw Material Cost
193.41
0
193.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.75
0
2.75
Selling and Distribution Expenses
87.70
0
87.70
Other Expenses
3.76
0.00
3.76
Total Expenditure (Excl Depreciation)
321.46
0
321.46
Operating Profit (PBDIT) excl Other Income
31.37
0.00
31.37
Other Income
41.17
0
41.17
Operating Profit (PBDIT)
128.39
0
128.39
Interest
2.75
0
2.75
Exceptional Items
-17.79
0
-17.79
Gross Profit (PBDT)
159.42
0
159.42
Depreciation
61.42
0
61.42
Profit Before Tax
46.43
0
46.43
Tax
8.36
0
8.36
Provisions and contingencies
0
0
0.00
Profit After Tax
41.70
0
41.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
41.70
0
41.70
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.68
0
-0.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.02
0
41.02
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,100.47
0
2,100.47
Earnings per share (EPS)
0.37
0
0.37
Diluted Earnings per share
0.37
0
0.37
Operating Profit Margin (Excl OI)
7.31%
0%
0.00
7.31%
Gross Profit Margin
30.57%
0%
0.00
30.57%
PAT Margin
11.82%
0%
0.00
11.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 35.28 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.31% vs 21.69% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 4.10 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 102.97% vs -62.10% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.72 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 59.71% vs -11.51% in Dec 2024
Annual - Interest
Interest 0.28 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -12.50% vs -3.03% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.31%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






